Brain inflammation is an important component of the pathogenesis of AD; thus, it is not surprising that the postmortem neocortex, hippocampus, and temporal cortex of AD patients present higher amounts of MPO protein compared with those of controls. This evidence concerns the gene MPO and Alzheimer disease.